Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LPCN

Lipocine (LPCN)

Lipocine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LPCN
DateTimeSourceHeadlineSymbolCompany
05/09/202423:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
05/09/202422:00PR Newswire (US)Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®NASDAQ:LPCNLipocine Inc
28/08/202401:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
27/08/202422:00PR Newswire (US)Lipocine to Present at H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:LPCNLipocine Inc
08/08/202422:00PR Newswire (US)Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2024NASDAQ:LPCNLipocine Inc
08/08/202420:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
08/08/202420:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPCNLipocine Inc
08/08/202406:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:LPCNLipocine Inc
25/06/202422:00PR Newswire (US)Lipocine Announces LPCN 1154 Meets Bioequivalence with IV Brexanolone in Pivotal StudyNASDAQ:LPCNLipocine Inc
10/06/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
10/06/202422:00PR Newswire (US)Lipocine Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late Breaking Session at EASL Congress 2024NASDAQ:LPCNLipocine Inc
08/06/202407:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPCNLipocine Inc
08/06/202407:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPCNLipocine Inc
08/06/202407:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPCNLipocine Inc
08/06/202407:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPCNLipocine Inc
08/06/202407:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPCNLipocine Inc
06/06/202406:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
04/06/202407:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
04/06/202407:09Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:LPCNLipocine Inc
09/05/202422:00PR Newswire (US)Lipocine Announces Financial Results for the First Quarter Ended March 31, 2024NASDAQ:LPCNLipocine Inc
09/05/202420:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPCNLipocine Inc
09/05/202420:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
08/05/202422:00PR Newswire (US)Lipocine Announces Late Breaking Oral Presentation of Data from the Phase 2 Study of LPCN 1148 at EASL Congress 2024NASDAQ:LPCNLipocine Inc
08/05/202420:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
01/05/202422:00PR Newswire (US)Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154NASDAQ:LPCNLipocine Inc
11/04/202421:00PR Newswire (US)Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with ObesityNASDAQ:LPCNLipocine Inc
28/03/202423:00PR Newswire (US)Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with CirrhosisNASDAQ:LPCNLipocine Inc
25/03/202423:00PR Newswire (US)Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154NASDAQ:LPCNLipocine Inc
08/03/202409:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPCNLipocine Inc
08/03/202400:00PR Newswire (US)Lipocine Announces Financial Results for the Full Year Ended December 31, 2023NASDAQ:LPCNLipocine Inc
 Showing the most relevant articles for your search:NASDAQ:LPCN